---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-011357"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2025-08-01T23:59:59+00:00"
generated_at: "2026-05-17T21:51:44.334772+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro issues 243,429 common shares on conversion of Series B Preferred (Jul 23-30, 2025)

## Summary
- 243,429 common shares issued upon conversion of ~564.76 shares of Series B Convertible Preferred Stock.
- Total common outstanding as of July 30, 2025: 3,139,861 shares.
- Issuance made in reliance on Section 4(a)(2) exemption from registration.

## SEC filing metadata
- accession: 0001214659-25-011357
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2025-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465925011357/0001214659-25-011357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925011357/i812508k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-011357
- JSON: https://secwatch.observer/filing/0001214659-25-011357.json
- Plain text: https://secwatch.observer/filing/0001214659-25-011357.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.